Search results
Author(s):
Brian Lindman
Added:
1 month ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
Author(s):
Reynald Evan R Tugade
,
Billy Joseph David
,
Clara S Tolentino
Added:
6 months ago
Author(s):
Bambang Dwiputra
,
Ade Meidian Ambari
,
Dwita Rian Desandri
,
et al
Added:
10 months ago
Author(s):
Aqtab Mazhar Alias
,
Raja Ezman Raja Shariff
,
Norashikin Saidon
,
et al
Added:
1 year ago
Author(s):
Fera Hidayati
,
Hana Soraya
,
Dicky Armein Hanafy
Added:
1 year ago
Author(s):
Christophe Leclercq
Added:
1 month ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire…
View more
Author(s):
Reynald Evan R Tugade
,
Nyssa Elline Palileo
,
Danica Ann Leycano
,
et al
Added:
6 months ago
Author(s):
Phattararuethai Sabkaewyod
,
Prin Vathesatogkit
,
Piyamitr Sritara
Added:
6 months ago
ESC 24: The SCOFF Trial
Author(s):
David Ferreira
Added:
8 months ago
Video
Author(s):
John Hummel
Added:
1 year ago
AHA 2023 — In this short interview, we are joined by Dr John Hummel (Ohio State University, US) to discuss the findings from the JEWEL-IDE (NCT05201495) study, which investigated the use of the Jewel patch-wearable cardioverter defibrillator (PWCD) system in participants who were at high risk for sudden cardiac arrest. This was a multicenter, prospective, single-arm trial, with 290 participants…
View more